464 related articles for article (PubMed ID: 34030476)
1. Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases.
Rodríguez Mesa XM; Moreno Vergara AF; Contreras Bolaños LA; Guevara Moriones N; Mejía Piñeros AL; Santander González SP
Cannabis Cannabinoid Res; 2021 Jun; 6(3):196-210. PubMed ID: 34030476
[No Abstract] [Full Text] [Related]
2. Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways.
Al-Ghezi ZZ; Miranda K; Nagarkatti M; Nagarkatti PS
Front Immunol; 2019; 10():1921. PubMed ID: 31497013
[TBL] [Abstract][Full Text] [Related]
3. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M
Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids decrease the th17 inflammatory autoimmune phenotype.
Kozela E; Juknat A; Kaushansky N; Rimmerman N; Ben-Nun A; Vogel Z
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1265-76. PubMed ID: 23892791
[TBL] [Abstract][Full Text] [Related]
5. Receptor-mediated effects of Δ
Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
[TBL] [Abstract][Full Text] [Related]
6. Joints for joints: cannabinoids in the treatment of rheumatoid arthritis.
Lowin T; Schneider M; Pongratz G
Curr Opin Rheumatol; 2019 May; 31(3):271-278. PubMed ID: 30920973
[TBL] [Abstract][Full Text] [Related]
7. A Critical Review of the Role of the Cannabinoid Compounds Δ
Jones É; Vlachou S
Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids and autoimmune diseases: A systematic review.
Katchan V; David P; Shoenfeld Y
Autoimmun Rev; 2016 Jun; 15(6):513-28. PubMed ID: 26876387
[TBL] [Abstract][Full Text] [Related]
9. The Anti-Inflammatory Effects of
Zaiachuk M; Suryavanshi SV; Pryimak N; Kovalchuk I; Kovalchuk O
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446655
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
[No Abstract] [Full Text] [Related]
11. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
12. Examining the role of cannabinoids on osteoporosis: a review.
Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK
Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of
Henshaw FR; Dewsbury LS; Lim CK; Steiner GZ
Cannabis Cannabinoid Res; 2021 Jun; 6(3):177-195. PubMed ID: 33998900
[No Abstract] [Full Text] [Related]
14. Cannabinoids as novel anti-inflammatory drugs.
Nagarkatti P; Pandey R; Rieder SA; Hegde VL; Nagarkatti M
Future Med Chem; 2009 Oct; 1(7):1333-49. PubMed ID: 20191092
[TBL] [Abstract][Full Text] [Related]
15. Cannabis sativa: Much more beyond Δ
Alves P; Amaral C; Teixeira N; Correia-da-Silva G
Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
[TBL] [Abstract][Full Text] [Related]
16. [Marihuana and cannobinoids as medicaments].
Tkaczyk M; Florek E; Piekoszewski W
Przegl Lek; 2012; 69(10):1095-7. PubMed ID: 23421098
[TBL] [Abstract][Full Text] [Related]
17. Medical cannabis and cannabinoids in rheumatology: where are we now?
Sarzi-Puttini P; Batticciotto A; Atzeni F; Bazzichi L; Di Franco M; Salaffi F; Marotto D; Ceribelli A; Ablin JN; Hauser W
Expert Rev Clin Immunol; 2019 Oct; 15(10):1019-1032. PubMed ID: 31512536
[No Abstract] [Full Text] [Related]
18. Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
Kozela E; Pietr M; Juknat A; Rimmerman N; Levy R; Vogel Z
J Biol Chem; 2010 Jan; 285(3):1616-26. PubMed ID: 19910459
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
20. Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment.
Asth L; Iglesias LP; De Oliveira AC; Moraes MFD; Moreira FA
Epilepsy Behav; 2021 Aug; 121(Pt B):106832. PubMed ID: 31839498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
